1.Harrison TR. Harrison's principle of internal medicine. 19th Edition ed. Harrison TR eUSM-HCp.
2.Ingale AS DJ, Health P. Prevalence of hypertension and its associated risk factors in adults: a unique study at field practice area of urban health training centre. 2017;4(2):572-81.
3.Liu F AD, Xie X, Li X-M, Fu Z-Y, Shan C-F, et al. Prevalence of isolated diastolic hypertension and associated risk factors among different ethnicity groups in Xinjiang, China. 2015;10(12):e0145325.
4.Unwin N SP, Rashid S, Mugusi F, Mbanya J-C, Kitange H, et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? 2001;79:947-53.
5.Mills KT BJ, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and ControlClinical Perspective: A Systematic Analysis of Population-Based Studies From 90 Countries. 2016;134(6):441-50.
6.Yoon SS FC, Carroll MD. Hypertension prevalence and control among adults: United States, 2011-2014: US Department of Health and Human Services, Centers for Disease Control and; 2015.
7.Gu D RK, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. 2002;40(6):920-7.
8.Mohammadi E AH, Gofranipour F, Jalali FJIjonp. Partnership caring: a theory of high blood pressure control in Iranian hypertensives. 2002;8(6):324-9.
9.Mbanya J ME, Salah J, Balkau BJIjoe. The prevalence of hypertension in rural and urban Cameroon. 1998;27(2):181-5.
10.Whelton PKJL. Epidemiology of hypertension. 1994;344(8915):101-6.
11.Eslami A, Lotfaliany M, Akbarpour S, Azizi F, Hadaegh FJG, international g. Trend of cardiovascular risk factors in the older Iranian population: 2002–2014. 2018;18(1):130-7.
12.Mohsenzadeh Y MM, Hemmati F, Sayehmiri K, Sarokhani MT, Sarokhani DJJoBRiMS. Investigating the prevalence rate of hypertension in Iranian men and women: A study of systematic review and meta-analysis. 2017;4(1):53-62.
13.Eslami A, Lotfaliany M, Akbarpour S, Azizi F, Hadaegh FJG, international g. Trend of cardiovascular risk factors in the older Iranian population: 2002–2014. 2018;18(1):130-7.
14.Robert E. Rakel DPR. Textbook of Family Medicine. NINTH EDITION ed. United States: Elsevier. 1447 p.
15.Anchala R KN, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. 2014;32(6):1170.
16.Chethana K AT, Mane A, Prasad VM, Sunkad VMJIJOCM, Health P. Prevalence of hypertension and its risk factors among adults in urban field practice area NMC, Raichur, Karnataka, India. 2016;4(1):45-50.
17.Chethana K, Anusha T, Mane A, Prasad VM, Sunkad VMJIJOCM, Health P. Prevalence of hypertension and its risk factors among adults in urban field practice area NMC, Raichur, Karnataka, India. 2016;4(1):45-50.
18.Jolly SE KK, Metzger JS, Day GM, Silverman A, Hopkins SE, et al. Prevalence of hypertension and associated risk factors in western alaska native people: The Western Alaska Tribal Collaborative for Health (WATCH) Study. 2015;17(10):812-8.
19.Kingue S NC, Menanga AP, Jingi AM, Noubiap JJN, Fesuh B, et al. Prevalence and risk factors of hypertension in urban areas of Cameroon: a nationwide population‐based cross‐sectional study. 2015;17(10):819-24.
20.Pinto IC MD, Therapeutics. Prevalence and risk factors of arterial hypertension: A literature review. 2017;1(2):1-7.
21.Do HT GJ, Le MB, Kok FJ, Feskens EJJAjoh. National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults. 2014;28(1):89-97.
22.Joshi MD AR, Njau EK, Wanjiru R, Kayima JK, Njeru EK, et al. Prevalence of hypertension and associated cardiovascular risk factors in an urban slum in Nairobi, Kenya: a population-based survey. 2014;14(1):1177.
23.Yang L YJ, Tang X, Xu X, Yu W, Wu HJPo. Prevalence, awareness, treatment, control and risk factors associated with hypertension among adults in Southern China, 2013. 2016;11(1):e0146181.
24.Ebrahimi M MM, Haghdoost AA, Abazari A, Alaeddini F, Mirzazadeh A, et al. Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006. Journal of hypertension. 2010;28(8):1620-9.
25.Esteghamati A AM, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. American journal of hypertension. 2008;21(6):620-6.
26.Sadeghi M RH, Kelishadi R. Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme. The Medical journal of Malaysia. 2004;59(4):460-7.
27.Ghorbani R, et al., Prevalence of hypertention among the adult population of Semnan province. Iraninan Journal of Endocrinology and MetabolismR(IJEM), 2009. 10(5 (SN 41)).
28.Taheri Tanjani P, et al.,Health status of elderly people in Khuzestan: A cross-sectional study. Iranian Journal of Diabetes and Lipid Disorders, 2017. 16(4): p. 191-200.
29.Lloyd-Sherlock P BJ, Minicuci N, Ebrahim S, Chatterji SJIjoe. Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control. 2014;43(1):116-28.
30. Najafi B, et al., Health status of elderly people in Sistan and Baluchistan province. Iranian Journal of Diabetes and Lipid Disorders, 2017. 16(5): p. 283-292.
31.Bromfield SG BC, Tanner RM, Peralta CA, Odden MC, Oparil S, et al. Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988–2010. 2014;16(4):270-6.
32.Delavari A, et al., Prevalence of hypertention in iranian urban and rural populations aged over 20 years in 2004 Journal of Mazandaran university of medical science,2007. 17(58).